XML 24 R7.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings/(Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
1.75% Convertible Notes due 2016
1.75% Convertible Notes due 2016
Common Stock
1.75% Convertible Notes due 2016
Additional Paid-in Capital
1.00% Convertible Notes due 2018
1.00% Convertible Notes due 2018
Common Stock
1.00% Convertible Notes due 2018
Additional Paid-in Capital
Balance (in shares) at Mar. 31, 2016   103,765   17,192                
Balance at Mar. 31, 2016 $ 581,385 $ 1,038 $ 1,088,628 $ (303,388) $ (166,997) $ (37,896)            
Increase (Decrease) in Stockholders' Equity                        
Net income 67,303 [1]       67,303              
Change in cumulative foreign currency translation adjustment (9,086)         (9,086)            
Net unrealized gain on available-for-sale securities, net of taxes (160)         (160)            
Stock-based compensation 88,378   88,378                  
Tax benefit associated with stock awards 1,990   1,990                  
Issuance of restricted stock, net of forfeitures and cancellations (in shares)   (1,738)                    
Issuance of restricted stock, net of forfeitures and cancellations 0 $ 17 (17)                  
Settlement/Conversion of Convertible Notes (in shares)               13,094     899  
Settlement/Conversion of Convertible Notes             $ 249,997 $ 131 $ 249,866 $ 18,341 $ 9 $ 18,332
Issuance of shares related to Social Point acquisition (in shares)   1,480                    
Issuance of shares related to Social Point acquisition 57,342 $ 15 57,327                  
Net share settlement of restricted stock awards (in shares)   (1,163)                    
Net share settlement of restricted stock awards (51,762) $ (12) (51,750)                  
Balance (in shares) at Mar. 31, 2017   119,813   17,192                
Balance at Mar. 31, 2017 1,003,728 $ 1,198 1,452,754 $ (303,388) (99,694) (47,142)            
Increase (Decrease) in Stockholders' Equity                        
Net income 173,533 [1]       173,533              
Change in cumulative foreign currency translation adjustment 43,379         43,379            
Change in unrealized gains on cash flow hedge, net (10,191)         (10,191)            
Net unrealized gain on available-for-sale securities, net of taxes (1,778)         (1,778)            
Stock-based compensation 293,214   293,214                  
Issuance of restricted stock, net of forfeitures and cancellations (in shares)   (2,151)                    
Issuance of restricted stock, net of forfeitures and cancellations 0 $ 21 (21)                  
Settlement/Conversion of Convertible Notes (in shares)                     12,082  
Settlement/Conversion of Convertible Notes                   255,084 $ 121 254,963
Repurchased common stock (in shares)       (1,513)                
Repurchased common stock (154,792)     $ (154,792)                
Net share settlement of restricted stock awards (in shares)   (1,303)                    
Net share settlement of restricted stock awards $ (112,884) $ (13) (112,871)                  
Balance (in shares) at Mar. 31, 2018 132,743 132,743   18,705                
Balance at Mar. 31, 2018 $ 1,488,970 $ 1,327 1,888,039 $ (458,180) 73,516 (15,732)            
Increase (Decrease) in Stockholders' Equity                        
Net income 333,837       333,837              
Change in cumulative foreign currency translation adjustment (33,456)         (33,456)            
Change in cumulative foreign currency translation adjustment (28,803)                      
Change in unrealized gains on cash flow hedge, net 4,906         4,906            
Net unrealized gain on available-for-sale securities, net of taxes 2,440         2,440            
Stock-based compensation 219,460   219,460                  
Issuance of restricted stock, net of forfeitures and cancellations (in shares)   (2,345)                    
Issuance of restricted stock, net of forfeitures and cancellations 0 $ 23 (23)                  
Settlement/Conversion of Convertible Notes (in shares)                     377  
Settlement/Conversion of Convertible Notes                   $ 8,112 $ 4 $ 8,108
Repurchased common stock (in shares)       (3,716)                
Repurchased common stock (362,392)     $ (362,392)                
Net share settlement of restricted stock awards (in shares)   (920)                    
Net share settlement of restricted stock awards (101,293) $ (9) (101,284)                  
Employee share purchase plan settlement (in shares)   57                    
Employee share purchase plan settlement $ 5,070 $ 1 5,069                  
Balance (in shares) at Mar. 31, 2019 134,602 134,602   22,421                
Balance at Mar. 31, 2019 $ 2,040,580 $ 1,346 $ 2,019,369 $ (820,572) $ 877,626 $ (37,189)            
[1] Prior period amounts have been adjusted retrospectively to reflect the adoption of ASU 2016-18, Statement of Cash Flows (Topic 230): RestrictedCash. Refer to Note 1 for further discussion.